PHILADELPHIA, Sept. 19, 2024 (GLOBE NEWSWIRE) — Kaskela Law LLC announces that it is investigating Doximity, Inc. (NYSE: DOCS) on behalf of the company’s long-term shareholders. Recently a securities fraud complaint was filed against Doximity on behalf of investors who purchased shares of the company’s stock between February 9, 2022, and April 1, 2024. According […]

Salt Lake City, Utah, Sept. 19, 2024 (GLOBE NEWSWIRE) — SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”) a leading innovator in ceramic manufacturing, today announced the successful completion of its previously announced “at-the-market” equity public offering (the “ATM Program”) which provided for the offer and sale, from time to time, of shares of

Preliminary finding of stable disease in two out of three patients at 6 months in the first subject cohort Combination of Ampligen and Imfinzi continues to be generally well-tolerated with no severe adverse events or dose-limiting toxicities OCALA, Fla., Sept. 19, 2024 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM”) today announced positive

TAMPA, Fla., Sept. 19, 2024 (GLOBE NEWSWIRE) — IT Nation, a global community of peers, thought leaders, and experts dedicated to elevating the IT ecosystem to new heights, has announced its new award program, the IT Nation Torch Awards, which will debut at this year’s IT Nation Connect event taking place from November 6-8, 2024,

– New U.S. patent covers the design and composition of the BVP – – Positive results from ongoing preclinical studies support the potential of the BVP to deliver insulin-producing islets as a potential treatment for type 1 diabetes – DURHAM, N.C., Sept. 19, 2024 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform

–Participant baseline characteristics in INFRONT-3 suggest a representative study population that enables testing of the effects of latozinemab in frontotemporal dementia with a progranulin gene mutation (FTD-GRN)– –Latozinemab, a novel investigational human monoclonal antibody, is the most advanced PGRN-elevating candidate in development for the treatment of FTD-GRN– SOUTH SAN FRANCISCO, Calif., Sept. 19, 2024 (GLOBE

CALGARY, Alberta, Sept. 19, 2024 (GLOBE NEWSWIRE) — Condor Energies Inc. (“Condor” or the “Company”) (TSX: CDR), a Canadian based energy transition company is pleased to announce that it has received its second natural gas allocation (“Gas Allocation”) from the Kazakhstan State authority responsible for gas distribution. The Gas Allocation will be used as feed

SAN JUAN, Puerto Rico, Sept. 19, 2024 (GLOBE NEWSWIRE) — Red Cat Holdings, Inc. (Nasdaq: RCAT) (“Red Cat” or the “Company”), a drone technology company integrating robotic hardware and software for military, government, and commercial operations, announces that financial results for the fiscal first quarter 2025 (3 months ended July 31, 2024) will be reported

VANCOUVER, British Columbia, Sept. 19, 2024 (GLOBE NEWSWIRE) — Gold Bull Resources Corp. (TSX-V: GBRC) (“Gold Bull” or the “Company“) is pleased to report results of ongoing exploration targeting field work completed at its Sandman project, located in Nevada, USA. New silver target emerges at K8 Prospect New prospect and drill target defined at “Abel

NAPLES, Fla., Sept. 19, 2024 (GLOBE NEWSWIRE) — via IBN – HealthLynked Corp. (OTCQB: HLYK), a leader in healthcare technology, is proud to announce its integration with Lyric Health, a comprehensive virtual care provider. This partnership enables HealthLynked to expand its telehealth services nationwide, offering patients in all 50 states convenient access to healthcare anytime,